Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

REVEALED: 5 | Vintage Vibes

3 Pharmaceutical Stocks Addressing Global Health Challenges

With the recent rise of diseases, pharmaceutical companies are pushing boundaries in medicine, from life-saving treatments to pioneering global healthcare solutions. Hence, investing in established pharmaceutical stocks, Pfizer (PFE), Johnson & Johnson (JNJ), and Merck & Co. (MRK) presents a compelling opportunity to capitalize for the long term. Read more.

StockNews.com

3 Blue-Chip Stocks with Strong Buy Ratings from Analysts

As a wave of volatility has been re-introduced to the system, investors are flocking toward blue-chip companies for stability and long-term growth potential. Thus, one could consider adding these three fundamentally sound blue-chip stocks, AbbVie (ABBV), Merck & Co. (MRK), and Johnson & Johnson (JNJ), with Strong Buy ratings from…

StockNews.com

Top 3 Discounted Dividend Stocks for 2025 That Could Skyrocket Your Portfolio

These three companies are leaders in their field, have a long history of increasing their dividends, and the stocks trade at a discount.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

3 Dividend Aristocrats Every Investor Should Own

Dividend Aristocrats are a shield during market turbulence and a key to diversified growth. Therefore, investors looking for stability and dependable income might consider adding fundamentally stable stocks Johnson & Johnson (JNJ), PepsiCo (PEP), and Kimberly-Clark (KMB). Continue reading….

StockNews.com

Johnson & Johnson's Quarterly Earnings Preview: What You Need to Know

Johnson & Johnson is poised to release its fiscal fourth-quarter earnings this month, and analysts project a double-digit profit decline.

Barchart

Bearish Screener Results: Bear Call Spread Opportunities for December 19th

Let’s take a look at Barchart’s Bear Call Spread Screener for December 19th:

Barchart

3 Healthcare Innovators Revolutionizing Patient Care

The healthcare sector is transforming with the adoption of digital technologies, improved productivity, and increasing R&D efforts. Thus, investors could consider quality healthcare innovator stocks Johnson & Johnson (JNJ), Merck & Co (MRK), and Bristol-Myers Squibb (BMY) as portfolio additions for potential gains. Continue reading.

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

3 Healthcare ETFs for a Balanced Investment Approach

For investors seeking a balanced approach, healthcare ETFs offer a combination of stability and growth potential. Therefore, it might be wise to consider Fidelity MSCI Health Care Index ETF (FHLC), iShares U.S. Healthcare ETF (IYH), and Vanguard Health Care Index Fund ETF Shares (VHT) for a balanced approach. Keep reading….

StockNews.com

Is Johnson & Johnson Stock Underperforming the Nasdaq?

Johnson & Johnson has underperformed the Nasdaq over the past year, but analysts are moderately optimistic about the stock’s prospects.

Barchart

3 Blue-Chip Stocks to Anchor Your Portfolio

Amid ongoing uncertainties surrounding the economy and global power dynamics, market volatility continues to dominate. In such times, investing in fundamentally sound blue-chip stocks, Johnson & Johnson (JNJ), American Express (AXP), and AT&T (T), could offer investors a stable foundation, serving as a buffer against market fluctuations and uncertainty. Read…

StockNews.com

Top 3 Dividend Aristocrats to Add to Your Portfolio

Dividend Aristocrats offer stability, reliable income, and risk mitigation, with consistent dividend growth helping to combat uncertain times. Hence, it could be wise to add top Dividend Aristocrats like Johnson & Johnson (JNJ), PepsiCo (PEP), and Kimberly-Clark (KMB) to your portfolio. Read on.

StockNews.com

3 Dividend Growth Stocks to Secure for Long-Term Wealth

During market volatility and economic downturns, investors often turn to stocks offering stable dividends and growth opportunities. Thus, quality dividend stocks Johnson & Johnson (JNJ), Lowe's Companies (LOW), and Target Corporation (TGT) could be ideal portfolio additions for long-term wealth. Continue reading.

StockNews.com

Are Wall Street Analysts Predicting Johnson & Johnson Stock Will Climb or Sink?

Johnson & Johnson has struggled to keep up with the broader market over the past year, and analysts are cautiously bullish on its future potential.

Barchart

3 Defensive Stocks to Buy as Market Volatility Rises

Amid current economic uncertainties and market volatility, investing in defensive stocks appears as an ideal strategy for portfolio protection. Thus, quality defensive stocks Johnson & Johnson (JNJ), Pfizer (PFE), and Genie Energy (GNE) could be ideal portfolio additions as market volatility rises. Continue reading.

StockNews.com

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

3 Healthcare Stocks for Long-Term Stability and Growth

With the rise of chronic diseases, technological advances and innovative drug pipelines are driving significant growth in the healthcare industry. Hence, investors may find long-term stability and exciting opportunities by adding stocks, Johnson & Johnson (JNJ), Pfizer (PFE), and Cigna Group (CI), to their portfolios. Read more….

StockNews.com

3 Dividend Stocks With 3% or More Yields to Watch Now

Dividend stocks are a top choice for long-term investors, with dependable payout and steady performance. Therefore, it could be wise to keep track of top dividend stocks, such as Johnson & Johnson (JNJ), Northwest Natural Holding Co. (NWN), and Universal Corp (UVV). Read more….

StockNews.com

3 Healthcare Stocks for Safe, Steady Growth

The healthcare industry is set for growth due to the growing demand for quality healthcare services and ongoing advancements in medical technology. Hence, investors might consider investing in healthcare stocks, Johnson & Johnson (JNJ), AbbVie (ABBV), and Thermo Fisher Scientific (TMO) for safe and steady growth. Read more….

Barchart

Johnson & Johnson's Q3 2024 Earnings: What to Expect

Johnson & Johnson is all set to announce its third-quarter results this month, and analysts are projecting double-digit earnings decline.

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

3 Top-Rated Dividend Aristocrats to Buy for Long-Term Growth

Dividend Aristocrats are known for their resilience during economic uncertainty, consistently providing stable income by increasing dividends, even amid inflation and rising unemployment. Hence, it could be wise to invest in top-rated Dividend Aristocrats like Johnson & Johnson (JNJ), Target (TGT), and Kimberly-Clark (KMB) for long-term growth. Read on.

Barchart

Is Johnson & Johnson Underperforming the S&P 500?

Johnson & Johnson has underperformed the S&P 500 recently, but analysts are moderately optimistic about the stock’s potential.

StockNews.com

3 Blue-Chip Stocks to Buy for Long-Term Security

Blue-chip stocks offer long-term security due to their strong financial stability, established market presence, and consistent performance. Amid this backdrop, it could be wise to invest in blue-chip stocks, Apple (AAPL), Johnson & Johnson (JNJ), and American Express (AXP) for long-term security. Continue reading.

StockNews.com

3 Healthcare Stocks With Strong Buy Ratings

The healthcare sector is proving to be a robust investment haven, particularly as it continues to evolve with groundbreaking technology and strong government support. Therefore, adding strong A-rated stocks like Johnson & Johnson (JNJ), AbbVie (ABBV), and Merck & Co. (MRK) could help garner significant returns. Read more….

StockNews.com

3 Inflation-Beating Stocks for Your Portfolio

Buying inflation-beating stocks helps preserve and grow the real value of your investments by outpacing rising prices and protecting against the eroding effects of inflation. Therefore, it could be wise to add inflation-beating stocks Walmart (WMT), Costco Wholesale (COST), and Johnson & Johnson (JNJ) to your portfolio. Read more.

Barchart

How High Can This Healthcare Stock Soar With Nvidia's Help?

Dividend King J&J can boost its MedTech business with Nvidia’s help.

StockNews.com

3 Bargain Healthcare Stocks to Buy for Long-Term Gains

The healthcare sector is poised for significant growth, driven by advancements in drug development, ongoing research and development (R&D) efforts, and its ability to remain resilient even during economic downturns. Thus, investors might consider buying bargain pharma stocks: Johnson & Johnson (JNJ), Merck & Co. (MRK), and AbbVie (ABBV) for…

1 … 4 5 6 7

People

Donald Trump

202,717 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the European Commission

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.